The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

All News

Investigating the human intestinal mucus barrier up-close and personal
Pharma & Human Health

Investigating the human intestinal mucus barrier up-close and personal

DEC 9, 2019
Da Volterra Announces Positive Results of a Phase 1 Drug-Drug Interaction Study
Clinical & Manufacturing

Da Volterra Announces Positive Results of a Phase 1 Drug-Drug Interaction Study

DEC 4, 2019
Caelus Health and Nestlé Health Science sign exclusive global development & option agreement
Biotics and Supplements

Caelus Health and Nestlé Health Science sign exclusive global development & option agreement

NOV 27, 2019
TargEDys, a French microbiome start-up, collects the award for “Best Nutraceutical Product of the Year”
Pharma & Human Health

TargEDys, a French microbiome start-up, collects the award for “Best Nutraceutical Product of the Year”

NOV 25, 2019
Preliminary Safety and Clinical Observations From 4D pharma’s Phase I/II Study of MRx0518 in Combination With KEYTRUDA®
Clinical & Manufacturing

Preliminary Safety and Clinical Observations From 4D pharma’s Phase I/II Study of MRx0518 in Combination With KEYTRUDA®

NOV 21, 2019
Cognate BioServices announces acquisition of Cobra Biologics
Finance

Cognate BioServices announces acquisition of Cobra Biologics

NOV 21, 2019
Beware probiotics in ICU patients
Biotics and Supplements

Beware probiotics in ICU patients

NOV 20, 2019
BIOCODEX enters exclusive negotiations for the acquisition of Laboratoires IPRAD
Finance

BIOCODEX enters exclusive negotiations for the acquisition of Laboratoires IPRAD

NOV 20, 2019
Fecal transplantation to treat patients with Parkinson’s disease: Hope or hype?
Biotics and Supplements

Fecal transplantation to treat patients with Parkinson’s disease: Hope or hype?

NOV 19, 2019
5-minute Microbiome Science Roundup: October 2019
Editor's Choice

5-minute Microbiome Science Roundup: October 2019

NOV 18, 2019
Doctors Come Together at FDA During C.diff Awareness Month, Advocate for Treatments
Pharma & Human Health

Doctors Come Together at FDA During C.diff Awareness Month, Advocate for Treatments

NOV 18, 2019